SUZHOU FUSE BIOSCIENCES

What this means for you

This application is over — abandoned 28 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97021067

Mark type

Stylized text

Filed

10 Sept 2021

Abandoned

28 Dec 2022

Attorney of record

Mark A. Jansen

Goods and services

• Class 005 — Pharmaceuticals: Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; preparations and substances for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of locoregionally active cytokines for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of oncology for medical purposes
• Class 042 — Scientific and technological services: Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; medical and scientific research and development for agents, preparations, products and technology in the field of immunocytokines; providing medical and scientific research information field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines for medical purposes; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services

Owner

• Suzhou Fuse Biosciences Limited, Jiangsu, CN

Prosecution history

• 13 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 13 Dec 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
• 13 Dec 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 13 Dec 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 10 Jan 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 10 Jan 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
• 10 Jan 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 27 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 27 Jun 2022 — NON-FINAL ACTION E-MAILED
• 27 Jun 2022 — NON-FINAL ACTION WRITTEN
• 15 Jun 2022 — ASSIGNED TO EXAMINER
• 19 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 14 Sept 2021 — NEW APPLICATION ENTERED